nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC2—skin of body—atopic dermatitis	0.0377	0.231	CbGeAlD
Dihydroxyaluminium—VDAC3—skin of body—atopic dermatitis	0.0314	0.192	CbGeAlD
Dihydroxyaluminium—VDAC1—skin of body—atopic dermatitis	0.0299	0.183	CbGeAlD
Dihydroxyaluminium—VDAC2—head—atopic dermatitis	0.0246	0.15	CbGeAlD
Dihydroxyaluminium—VDAC3—head—atopic dermatitis	0.0205	0.125	CbGeAlD
Dihydroxyaluminium—VDAC1—head—atopic dermatitis	0.0195	0.119	CbGeAlD
Dihydroxyaluminium—Acidosis—Tacrolimus—atopic dermatitis	0.0155	0.0198	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Loratadine—atopic dermatitis	0.0143	0.0183	CcSEcCtD
Dihydroxyaluminium—VDAC1—Temsirolimus—Pimecrolimus—atopic dermatitis	0.0141	0.262	CbGdCrCtD
Dihydroxyaluminium—VDAC1—Temsirolimus—Tacrolimus—atopic dermatitis	0.0141	0.262	CbGdCrCtD
Dihydroxyaluminium—Fluid overload—Tacrolimus—atopic dermatitis	0.0138	0.0176	CcSEcCtD
Dihydroxyaluminium—Encephalopathy—Tacrolimus—atopic dermatitis	0.0134	0.0171	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Hydrocortisone—atopic dermatitis	0.0128	0.0164	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Loratadine—atopic dermatitis	0.0122	0.0156	CcSEcCtD
Dihydroxyaluminium—Lung disorder—Tacrolimus—atopic dermatitis	0.0121	0.0155	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Methylprednisolone—atopic dermatitis	0.012	0.0154	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Diphenhydramine—atopic dermatitis	0.0112	0.0144	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Dimenhydrinate—atopic dermatitis	0.0112	0.0144	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Dexamethasone—atopic dermatitis	0.0109	0.014	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Betamethasone—atopic dermatitis	0.0109	0.014	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Tacrolimus—atopic dermatitis	0.00976	0.0125	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Fluocinolone Acetonide—atopic dermatitis	0.00864	0.011	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Pimecrolimus—atopic dermatitis	0.00793	0.0101	CcSEcCtD
Dihydroxyaluminium—Infection—Desonide—atopic dermatitis	0.00791	0.0101	CcSEcCtD
Dihydroxyaluminium—Coma—Tacrolimus—atopic dermatitis	0.00783	0.01	CcSEcCtD
Dihydroxyaluminium—Chills—Dimenhydrinate—atopic dermatitis	0.00734	0.00938	CcSEcCtD
Dihydroxyaluminium—Chills—Diphenhydramine—atopic dermatitis	0.00734	0.00938	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Tacrolimus—atopic dermatitis	0.00722	0.00923	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Tacrolimus—atopic dermatitis	0.00719	0.00918	CcSEcCtD
Dihydroxyaluminium—Pain—Desonide—atopic dermatitis	0.00681	0.0087	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Diphenhydramine—atopic dermatitis	0.00671	0.00858	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Dimenhydrinate—atopic dermatitis	0.00671	0.00858	CcSEcCtD
Dihydroxyaluminium—Back pain—Pimecrolimus—atopic dermatitis	0.00666	0.00851	CcSEcCtD
Dihydroxyaluminium—Thirst—Tacrolimus—atopic dermatitis	0.00654	0.00835	CcSEcCtD
Dihydroxyaluminium—Infection—Fluocinonide—atopic dermatitis	0.00641	0.00819	CcSEcCtD
Dihydroxyaluminium—Vertigo—Dimenhydrinate—atopic dermatitis	0.0064	0.00818	CcSEcCtD
Dihydroxyaluminium—Vertigo—Diphenhydramine—atopic dermatitis	0.0064	0.00818	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Tacrolimus—atopic dermatitis	0.00625	0.00798	CcSEcCtD
Dihydroxyaluminium—Convulsion—Diphenhydramine—atopic dermatitis	0.00617	0.00789	CcSEcCtD
Dihydroxyaluminium—Convulsion—Dimenhydrinate—atopic dermatitis	0.00617	0.00789	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Tacrolimus—atopic dermatitis	0.00592	0.00756	CcSEcCtD
Dihydroxyaluminium—Dehydration—Tacrolimus—atopic dermatitis	0.00579	0.00739	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Desonide—atopic dermatitis	0.00575	0.107	CbGdCrCtD
Dihydroxyaluminium—Rhinitis—Fluocinolone Acetonide—atopic dermatitis	0.00568	0.00726	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00567	0.00725	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Diphenhydramine—atopic dermatitis	0.00567	0.00725	CcSEcCtD
Dihydroxyaluminium—Oedema—Pimecrolimus—atopic dermatitis	0.00562	0.00718	CcSEcCtD
Dihydroxyaluminium—Infection—Pimecrolimus—atopic dermatitis	0.00559	0.00714	CcSEcCtD
Dihydroxyaluminium—Pain—Fluocinonide—atopic dermatitis	0.00551	0.00705	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Fluocinolone Acetonide—atopic dermatitis	0.00546	0.00697	CcSEcCtD
Dihydroxyaluminium—Hypotension—Dimenhydrinate—atopic dermatitis	0.00543	0.00694	CcSEcCtD
Dihydroxyaluminium—Hypotension—Diphenhydramine—atopic dermatitis	0.00543	0.00694	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Mometasone—atopic dermatitis	0.00542	0.00693	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Tacrolimus—atopic dermatitis	0.00524	0.00669	CcSEcCtD
Dihydroxyaluminium—Extravasation—Betamethasone—atopic dermatitis	0.00524	0.00669	CcSEcCtD
Dihydroxyaluminium—Extravasation—Dexamethasone—atopic dermatitis	0.00524	0.00669	CcSEcCtD
Dihydroxyaluminium—Pain—Pimecrolimus—atopic dermatitis	0.00481	0.00614	CcSEcCtD
Dihydroxyaluminium—Back pain—Fluocinolone Acetonide—atopic dermatitis	0.00477	0.00609	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Fluocinonide—atopic dermatitis	0.00475	0.00607	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.00465	0.00594	CcSEcCtD
Dihydroxyaluminium—Urticaria—Diphenhydramine—atopic dermatitis	0.00462	0.0059	CcSEcCtD
Dihydroxyaluminium—Urticaria—Dimenhydrinate—atopic dermatitis	0.00462	0.0059	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Fluocinonide—atopic dermatitis	0.00461	0.0856	CbGdCrCtD
Dihydroxyaluminium—Thrombophlebitis—Prednisolone—atopic dermatitis	0.00459	0.00587	CcSEcCtD
Dihydroxyaluminium—Back pain—Mometasone—atopic dermatitis	0.00455	0.00582	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Hydrocortisone—atopic dermatitis	0.00448	0.00573	CcSEcCtD
Dihydroxyaluminium—Urticaria—Pimecrolimus—atopic dermatitis	0.00447	0.00571	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Pimecrolimus—atopic dermatitis	0.00444	0.00568	CcSEcCtD
Dihydroxyaluminium—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.00443	0.00566	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Loratadine—atopic dermatitis	0.00437	0.00558	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Tacrolimus—atopic dermatitis	0.00432	0.00551	CcSEcCtD
Dihydroxyaluminium—Dizziness—Fluocinonide—atopic dermatitis	0.00426	0.00545	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Triamcinolone—atopic dermatitis	0.00422	0.00539	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Methylprednisolone—atopic dermatitis	0.00421	0.00538	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Prednisolone—atopic dermatitis	0.00419	0.00536	CcSEcCtD
Dihydroxyaluminium—Hypotension—Loratadine—atopic dermatitis	0.00418	0.00535	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Tacrolimus—atopic dermatitis	0.00415	0.0053	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.00414	0.00529	CcSEcCtD
Dihydroxyaluminium—Oedema—Fluocinolone Acetonide—atopic dermatitis	0.00402	0.00514	CcSEcCtD
Dihydroxyaluminium—Infection—Fluocinolone Acetonide—atopic dermatitis	0.004	0.00511	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00398	0.00508	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00398	0.00508	CcSEcCtD
Dihydroxyaluminium—Chills—Tacrolimus—atopic dermatitis	0.00386	0.00494	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00385	0.00491	CcSEcCtD
Dihydroxyaluminium—Dizziness—Diphenhydramine—atopic dermatitis	0.00384	0.00491	CcSEcCtD
Dihydroxyaluminium—Dizziness—Dimenhydrinate—atopic dermatitis	0.00384	0.00491	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Dexamethasone—atopic dermatitis	0.00383	0.0049	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Betamethasone—atopic dermatitis	0.00383	0.0049	CcSEcCtD
Dihydroxyaluminium—Pain—Loratadine—atopic dermatitis	0.00383	0.00489	CcSEcCtD
Dihydroxyaluminium—Infection—Mometasone—atopic dermatitis	0.00382	0.00488	CcSEcCtD
Dihydroxyaluminium—Vomiting—Dimenhydrinate—atopic dermatitis	0.0037	0.00472	CcSEcCtD
Dihydroxyaluminium—Vomiting—Diphenhydramine—atopic dermatitis	0.0037	0.00472	CcSEcCtD
Dihydroxyaluminium—Back pain—Tacrolimus—atopic dermatitis	0.00362	0.00463	CcSEcCtD
Dihydroxyaluminium—Vomiting—Pimecrolimus—atopic dermatitis	0.00357	0.00457	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Mometasone—atopic dermatitis	0.00357	0.0664	CbGdCrCtD
Dihydroxyaluminium—Body temperature increased—Loratadine—atopic dermatitis	0.00354	0.00452	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Tacrolimus—atopic dermatitis	0.00353	0.00451	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Dexamethasone—atopic dermatitis	0.0035	0.00447	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Betamethasone—atopic dermatitis	0.0035	0.00447	CcSEcCtD
Dihydroxyaluminium—Nausea—Dimenhydrinate—atopic dermatitis	0.00345	0.00441	CcSEcCtD
Dihydroxyaluminium—Nausea—Diphenhydramine—atopic dermatitis	0.00345	0.00441	CcSEcCtD
Dihydroxyaluminium—Pain—Fluocinolone Acetonide—atopic dermatitis	0.00344	0.0044	CcSEcCtD
Dihydroxyaluminium—Vertigo—Tacrolimus—atopic dermatitis	0.00337	0.0043	CcSEcCtD
Dihydroxyaluminium—Nausea—Pimecrolimus—atopic dermatitis	0.00334	0.00427	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Prednisone—atopic dermatitis	0.00334	0.00426	CcSEcCtD
Dihydroxyaluminium—Pain—Mometasone—atopic dermatitis	0.00329	0.0042	CcSEcCtD
Dihydroxyaluminium—Convulsion—Tacrolimus—atopic dermatitis	0.00325	0.00415	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.00318	0.00406	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Loratadine—atopic dermatitis	0.00306	0.00391	CcSEcCtD
Dihydroxyaluminium—Oedema—Tacrolimus—atopic dermatitis	0.00306	0.00391	CcSEcCtD
Dihydroxyaluminium—Infection—Tacrolimus—atopic dermatitis	0.00304	0.00388	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Mometasone—atopic dermatitis	0.00304	0.00388	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Tacrolimus—atopic dermatitis	0.00299	0.00381	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00297	0.00379	CcSEcCtD
Dihydroxyaluminium—Dizziness—Loratadine—atopic dermatitis	0.00296	0.00378	CcSEcCtD
Dihydroxyaluminium—Hypotension—Tacrolimus—atopic dermatitis	0.00286	0.00365	CcSEcCtD
Dihydroxyaluminium—Vomiting—Loratadine—atopic dermatitis	0.00285	0.00364	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00275	0.00352	CcSEcCtD
Dihydroxyaluminium—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00266	0.0034	CcSEcCtD
Dihydroxyaluminium—Nausea—Loratadine—atopic dermatitis	0.00266	0.0034	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Prednisolone—atopic dermatitis	0.00265	0.00339	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Mometasone—atopic dermatitis	0.00263	0.00336	CcSEcCtD
Dihydroxyaluminium—Pain—Tacrolimus—atopic dermatitis	0.00262	0.00334	CcSEcCtD
Dihydroxyaluminium—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00256	0.00327	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Triamcinolone—atopic dermatitis	0.00254	0.00324	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Methylprednisolone—atopic dermatitis	0.00253	0.00323	CcSEcCtD
Dihydroxyaluminium—Vomiting—Mometasone—atopic dermatitis	0.00244	0.00312	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Methylprednisolone—atopic dermatitis	0.00243	0.00311	CcSEcCtD
Dihydroxyaluminium—Urticaria—Tacrolimus—atopic dermatitis	0.00243	0.0031	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Tacrolimus—atopic dermatitis	0.00242	0.00309	CcSEcCtD
Dihydroxyaluminium—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00239	0.00305	CcSEcCtD
Dihydroxyaluminium—Nausea—Mometasone—atopic dermatitis	0.00228	0.00292	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Prednisolone—atopic dermatitis	0.00226	0.00288	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00225	0.00288	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Dexamethasone—atopic dermatitis	0.00221	0.00283	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Betamethasone—atopic dermatitis	0.00221	0.00283	CcSEcCtD
Dihydroxyaluminium—Vertigo—Prednisolone—atopic dermatitis	0.00215	0.00275	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Methylprednisolone—atopic dermatitis	0.00213	0.0396	CbGdCrCtD
Dihydroxyaluminium—Back pain—Triamcinolone—atopic dermatitis	0.00213	0.00272	CcSEcCtD
Dihydroxyaluminium—Vertigo—Hydrocortisone—atopic dermatitis	0.0021	0.00268	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Betamethasone—atopic dermatitis	0.0021	0.039	CbGdCrCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Dexamethasone—atopic dermatitis	0.0021	0.039	CbGdCrCtD
Dihydroxyaluminium—Diarrhoea—Tacrolimus—atopic dermatitis	0.00209	0.00267	CcSEcCtD
Dihydroxyaluminium—Convulsion—Prednisolone—atopic dermatitis	0.00207	0.00265	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Triamcinolone—atopic dermatitis	0.00205	0.0381	CbGdCrCtD
Dihydroxyaluminium—Convulsion—Hydrocortisone—atopic dermatitis	0.00203	0.00259	CcSEcCtD
Dihydroxyaluminium—Dizziness—Tacrolimus—atopic dermatitis	0.00202	0.00258	CcSEcCtD
Dihydroxyaluminium—Vertigo—Triamcinolone—atopic dermatitis	0.00198	0.00253	CcSEcCtD
Dihydroxyaluminium—Vertigo—Methylprednisolone—atopic dermatitis	0.00197	0.00252	CcSEcCtD
Dihydroxyaluminium—Oedema—Prednisolone—atopic dermatitis	0.00195	0.0025	CcSEcCtD
Dihydroxyaluminium—Vomiting—Tacrolimus—atopic dermatitis	0.00194	0.00248	CcSEcCtD
Dihydroxyaluminium—Oedema—Hydrocortisone—atopic dermatitis	0.00191	0.00244	CcSEcCtD
Dihydroxyaluminium—Convulsion—Triamcinolone—atopic dermatitis	0.00191	0.00244	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Prednisolone—atopic dermatitis	0.00191	0.00244	CcSEcCtD
Dihydroxyaluminium—Convulsion—Methylprednisolone—atopic dermatitis	0.0019	0.00243	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Prednisolone—atopic dermatitis	0.0019	0.0353	CbGdCrCtD
Dihydroxyaluminium—Infection—Hydrocortisone—atopic dermatitis	0.0019	0.00242	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Hydrocortisone—atopic dermatitis	0.00186	0.00238	CcSEcCtD
Dihydroxyaluminium—Nausea—Tacrolimus—atopic dermatitis	0.00182	0.00232	CcSEcCtD
Dihydroxyaluminium—Oedema—Triamcinolone—atopic dermatitis	0.0018	0.0023	CcSEcCtD
Dihydroxyaluminium—Vertigo—Betamethasone—atopic dermatitis	0.00179	0.00229	CcSEcCtD
Dihydroxyaluminium—Vertigo—Dexamethasone—atopic dermatitis	0.00179	0.00229	CcSEcCtD
Dihydroxyaluminium—Infection—Triamcinolone—atopic dermatitis	0.00178	0.00228	CcSEcCtD
Dihydroxyaluminium—Hypotension—Hydrocortisone—atopic dermatitis	0.00178	0.00228	CcSEcCtD
Dihydroxyaluminium—Infection—Methylprednisolone—atopic dermatitis	0.00178	0.00228	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Triamcinolone—atopic dermatitis	0.00175	0.00224	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Methylprednisolone—atopic dermatitis	0.00175	0.00224	CcSEcCtD
Dihydroxyaluminium—Convulsion—Dexamethasone—atopic dermatitis	0.00173	0.00221	CcSEcCtD
Dihydroxyaluminium—Convulsion—Betamethasone—atopic dermatitis	0.00173	0.00221	CcSEcCtD
Dihydroxyaluminium—Hypotension—Methylprednisolone—atopic dermatitis	0.00167	0.00214	CcSEcCtD
Dihydroxyaluminium—Pain—Prednisolone—atopic dermatitis	0.00167	0.00213	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Prednisone—atopic dermatitis	0.00164	0.00209	CcSEcCtD
Dihydroxyaluminium—Pain—Hydrocortisone—atopic dermatitis	0.00163	0.00208	CcSEcCtD
Dihydroxyaluminium—Oedema—Dexamethasone—atopic dermatitis	0.00163	0.00208	CcSEcCtD
Dihydroxyaluminium—Oedema—Betamethasone—atopic dermatitis	0.00163	0.00208	CcSEcCtD
Dihydroxyaluminium—Infection—Betamethasone—atopic dermatitis	0.00162	0.00207	CcSEcCtD
Dihydroxyaluminium—Infection—Dexamethasone—atopic dermatitis	0.00162	0.00207	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Betamethasone—atopic dermatitis	0.00159	0.00203	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Dexamethasone—atopic dermatitis	0.00159	0.00203	CcSEcCtD
Dihydroxyaluminium—Vertigo—Prednisone—atopic dermatitis	0.00156	0.002	CcSEcCtD
Dihydroxyaluminium—Urticaria—Prednisolone—atopic dermatitis	0.00155	0.00198	CcSEcCtD
Dihydroxyaluminium—Pain—Triamcinolone—atopic dermatitis	0.00154	0.00196	CcSEcCtD
Dihydroxyaluminium—Hypotension—Dexamethasone—atopic dermatitis	0.00152	0.00195	CcSEcCtD
Dihydroxyaluminium—Hypotension—Betamethasone—atopic dermatitis	0.00152	0.00195	CcSEcCtD
Dihydroxyaluminium—Urticaria—Hydrocortisone—atopic dermatitis	0.00152	0.00194	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Hydrocortisone—atopic dermatitis	0.00151	0.00193	CcSEcCtD
Dihydroxyaluminium—Convulsion—Prednisone—atopic dermatitis	0.00151	0.00193	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Prednisolone—atopic dermatitis	0.00144	0.00184	CcSEcCtD
Dihydroxyaluminium—Urticaria—Triamcinolone—atopic dermatitis	0.00143	0.00182	CcSEcCtD
Dihydroxyaluminium—Urticaria—Methylprednisolone—atopic dermatitis	0.00142	0.00182	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Triamcinolone—atopic dermatitis	0.00142	0.00181	CcSEcCtD
Dihydroxyaluminium—Oedema—Prednisone—atopic dermatitis	0.00142	0.00181	CcSEcCtD
Dihydroxyaluminium—Infection—Prednisone—atopic dermatitis	0.00141	0.0018	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.00141	0.0018	CcSEcCtD
Dihydroxyaluminium—Pain—Betamethasone—atopic dermatitis	0.00139	0.00178	CcSEcCtD
Dihydroxyaluminium—Pain—Dexamethasone—atopic dermatitis	0.00139	0.00178	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Prednisone—atopic dermatitis	0.00139	0.00177	CcSEcCtD
Dihydroxyaluminium—VDAC1—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.00137	0.0254	CbGdCrCtD
Dihydroxyaluminium—Hypersensitivity—Triamcinolone—atopic dermatitis	0.00132	0.00169	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.00132	0.00169	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00131	0.00167	CcSEcCtD
Dihydroxyaluminium—Urticaria—Dexamethasone—atopic dermatitis	0.00129	0.00165	CcSEcCtD
Dihydroxyaluminium—Urticaria—Betamethasone—atopic dermatitis	0.00129	0.00165	CcSEcCtD
Dihydroxyaluminium—Dizziness—Prednisolone—atopic dermatitis	0.00129	0.00165	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Dexamethasone—atopic dermatitis	0.00129	0.00165	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Betamethasone—atopic dermatitis	0.00129	0.00165	CcSEcCtD
Dihydroxyaluminium—Dizziness—Hydrocortisone—atopic dermatitis	0.00126	0.00161	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00123	0.00157	CcSEcCtD
Dihydroxyaluminium—Vomiting—Hydrocortisone—atopic dermatitis	0.00121	0.00155	CcSEcCtD
Dihydroxyaluminium—Dizziness—Triamcinolone—atopic dermatitis	0.00119	0.00152	CcSEcCtD
Dihydroxyaluminium—Dizziness—Methylprednisolone—atopic dermatitis	0.00119	0.00151	CcSEcCtD
Dihydroxyaluminium—Nausea—Prednisolone—atopic dermatitis	0.00116	0.00148	CcSEcCtD
Dihydroxyaluminium—Vomiting—Triamcinolone—atopic dermatitis	0.00114	0.00146	CcSEcCtD
Dihydroxyaluminium—Vomiting—Methylprednisolone—atopic dermatitis	0.00114	0.00146	CcSEcCtD
Dihydroxyaluminium—Nausea—Hydrocortisone—atopic dermatitis	0.00113	0.00145	CcSEcCtD
Dihydroxyaluminium—Urticaria—Prednisone—atopic dermatitis	0.00113	0.00144	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Prednisone—atopic dermatitis	0.00112	0.00143	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Dexamethasone—atopic dermatitis	0.00112	0.00142	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Betamethasone—atopic dermatitis	0.00112	0.00142	CcSEcCtD
Dihydroxyaluminium—Dizziness—Dexamethasone—atopic dermatitis	0.00108	0.00138	CcSEcCtD
Dihydroxyaluminium—Dizziness—Betamethasone—atopic dermatitis	0.00108	0.00138	CcSEcCtD
Dihydroxyaluminium—Nausea—Triamcinolone—atopic dermatitis	0.00107	0.00136	CcSEcCtD
Dihydroxyaluminium—Nausea—Methylprednisolone—atopic dermatitis	0.00106	0.00136	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Prednisone—atopic dermatitis	0.00105	0.00134	CcSEcCtD
Dihydroxyaluminium—Vomiting—Betamethasone—atopic dermatitis	0.00104	0.00132	CcSEcCtD
Dihydroxyaluminium—Vomiting—Dexamethasone—atopic dermatitis	0.00104	0.00132	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Prednisone—atopic dermatitis	0.000971	0.00124	CcSEcCtD
Dihydroxyaluminium—Nausea—Betamethasone—atopic dermatitis	0.000968	0.00124	CcSEcCtD
Dihydroxyaluminium—Nausea—Dexamethasone—atopic dermatitis	0.000968	0.00124	CcSEcCtD
Dihydroxyaluminium—Dizziness—Prednisone—atopic dermatitis	0.000939	0.0012	CcSEcCtD
Dihydroxyaluminium—Vomiting—Prednisone—atopic dermatitis	0.000903	0.00115	CcSEcCtD
Dihydroxyaluminium—Nausea—Prednisone—atopic dermatitis	0.000843	0.00108	CcSEcCtD
